Oxidation of tricyclic antidepressant drugs, debrisoquine and 7-ethoxyresorufin, by human liver preparations

scientific article published on 01 May 1986

Oxidation of tricyclic antidepressant drugs, debrisoquine and 7-ethoxyresorufin, by human liver preparations is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.3109/00498258609050247
P698PubMed publication ID3739365

P50authorEdward T MorganQ56807124
P2093author name stringM Göransson
E Spina
O Eriksson
K Woodhouse
C Birgersson
C von Bahr
P433issue5
P304page(s)391-400
P577publication date1986-05-01
P1433published inXenobioticaQ1360678
P1476titleOxidation of tricyclic antidepressant drugs, debrisoquine and 7-ethoxyresorufin, by human liver preparations
P478volume16

Reverse relations

cites work (P2860)
Q30661187Clomipramine metabolism. Model-based analysis of variability factors from drug monitoring data
Q59389103Debrisoquine oxidative phenotyping and psychiatric drug treatment
Q36244452Genetic Aspects of Drug Disposition and Therapeutics
Q69827683High-performance liquid chromatographic quantitation of 4-hydroxydebrisoquine in microsomal incubates by use of silica columns, aqueous mobile phase and automated column switching
Q43907841Inhibition and metabolite complexation of rat hepatic microsomal cytochrome p450 by tricyclic antidepressants
Q69749394Quinidine inhibits the 2-hydroxylation of imipramine and desipramine but not the demethylation of imipramine
Q69649978The influence of cimetidine on debrisoquine 4-hydroxylation in extensive metabolizers
Q47722116Time course of enzyme induction in humans: effect of pentobarbital on nortriptyline metabolism

Search more.